0001062993-24-006184.txt : 20240311
0001062993-24-006184.hdr.sgml : 20240311
20240311193746
ACCESSION NUMBER: 0001062993-24-006184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pfeiffenberger Brent
CENTRAL INDEX KEY: 0002001162
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39292
FILM NUMBER: 24739785
MAIL ADDRESS:
STREET 1: C/O CENTURY THERAPEUTICS, INC.
STREET 2: 25 N 38TH STREET, 11TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Butterfly Network, Inc.
CENTRAL INDEX KEY: 0001804176
STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 DISTRICT AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-557-4800
MAIL ADDRESS:
STREET 1: 1600 DISTRICT AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
FORMER COMPANY:
FORMER CONFORMED NAME: Longview Acquisition Corp.
DATE OF NAME CHANGE: 20200220
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-03-07
0001804176
Butterfly Network, Inc.
BFLY
0002001162
Pfeiffenberger Brent
C/O CENTURY THERAPEUTICS, INC.
25 N 38TH STREET, 11TH FLOOR
PHILADELPHIA
PA
19104
1
1
0
0
President and CEO
0
Common Stock
2024-03-07
4
A
0
17425
0
A
1470704
D
Stock Option (right to buy)
5.32
2024-03-07
4
A
0
104550
0
A
2034-03-07
Common Stock
104550
104550
D
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on March 7, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
The option vests 25% on March 7, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.
Exhibit 24 - Power of Attorney
/s/ Douglas Carr, Attorney-in-Fact
2024-03-11
EX-24.1
2
exhibit24-1.txt
POA
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby
constitutes and appoints each of Douglas Carr and Gregory Russotti
of Century Therapeutics, Inc. (the "Company"), signing singly, and
with full power of substitution, as the undersigned's true and
lawful attorney-in-fact to:
1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of the Company,
Forms 3, 4 and 5, in accordance with Section 16(a) of the Securities
Exchange Act of 1934 and the rules thereunder;
2) do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to (A) complete
and execute any such Forms 3, 4 or 5 (B), complete and execute any
amendment or amendments thereto, and (C) timely file such forms with
the United States Securities and Exchange Commission and any stock
exchange or similar authority; and
3) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents executed
by such attorney-in-fact on behalf of the undersigned pursuant to
this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and perform any and
every act and thing whatsoever requisite, necessary or proper to be
done in the exercise of any of the rights and powers herein granted,
as fully to all intents and purposes as the undersigned might or
could do if personally present with full power of substitution or
revocation, hereby ratifying and confirming all that each such
attorney-in-fact or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of
the undersigned, is not assuming, nor is the Company assuming, any
of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms
3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 11th day of March, 2024.
/s/ Brent Pfeiffenberger
Name: Brent Pfeiffenberger